Myocardial Infarction Market Is Estimated To Witness High Growth Owing To Increasing Incidence Rates And Expanding Geriatric Population

Myocardial Infarction Market

The Myocardial Infarction Market is estimated to be valued at US$ 1,816.8 Mn in 2023 and is expected to exhibit a CAGR of 5.9 % over the forecast period from 2021 to 2028, as highlighted in a new report published by Coherent Market Insights.


Market Overview:
Myocardial infarction, commonly known as a heart attack, occurs due to reduced blood flow and oxygen delivery to the heart muscle. It damages heart muscles due to blockage in coronary arteries. Some key symptoms include chest pain, shortness of breath, nausea etc. Major treatment types include medication such as antiplatelets, beta-blockers and statins. Other treatment options include procedures such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).

Market Dynamics:
The myocardial infarction market is mainly driven by increasing incidence rates of myocardial infarction globally. According to World Health Organization (WHO), cardiovascular diseases (CVDs) kill over 17.9 million people annually, representing 31% of all global deaths. Out of which, myocardial infarction alone is responsible for 8.9 million deaths. Further, expanding geriatric population base is also fueling the market growth. As per UN population data, number of elderly (aged 65 years or over) is projected to grow to 1.5 billion in 2050 from 703 million in 2019, largely driving the need for myocardial infarction treatment. Additionally, ongoing development of advanced medication and treatment devices for myocardial infarction management provides lucrative opportunities for market players over the forecast period.

SWOT Analysis

Strength: The myocardial infarction market has strong research and development capabilities. New drugs and devices are being developed which can effectively treat myocardial infarction. The advanced healthcare infrastructure and availability of skilled medical professionals provide better treatment options.

Weakness: High cost of treatment procedures and devices makes it inaccessible for many. Risk of side effects associated with few drugs may discourage their use. Lack of awareness about symptoms of heart attack in many regions.

Opportunity: Increasing awareness programs by governments and NGOs can help identify heart attacks early. Growth in medical tourism in developing nations provides scope for newer revenues. Rise in obese population and changing lifestyles leading to more heart diseases presents an opportunity.

Threats: Price controls and regulatory norms can hamper pricing flexibility for companies. Emergence of alternative treatment methods may pose competitive threats. uncertainty regarding reimbursement policies can negatively impact market revenues.

Key Takeaways

The  Global Myocardial Infarction Market is expected to witness high growth, exhibiting CAGR of 5.9% over the forecast period, due to increasing prevalence of cardiovascular diseases. According to WHO cardiovascular diseases are the leading cause of death globally. Advances in treatments and awareness are supporting the market growth.

Regional analysis - North America dominates the myocardial infarction market currently due to high healthcare spending and regulatory support for new treatments. However, Asia Pacific is expected to grow at fastest pace due to rising medical tourism, large patient population and increasing healthcare investments.

Key players - Key players operating in the myocardial infarction market are Bristol-Myers Squibb Co., Bayer AG, Johnson & Johnson Services Inc., Sanofi S.A., Novartis International AG, AstraZeneca plc., Daiichi Sankyo Co Ltd, Boehringer Ingelheim International GmbH, Pfizer Inc., and Merck KGaA. These companies are focusing on new drug and device launches to strengthen their market positions.

Read More - https://www.dailyprbulletin.com/rising-demand-for-advanced-therapeutics-set-to-propel-growth-of-global-myocardial-infarction-market-over-2028-30-size/ 

Comments

Post a Comment

Popular posts from this blog

Optical Transport Network Market Is Estimated To Witness High Growth Owing To Opportunity In Deployment Of 400G Systems

Image
Optical Transport Network Market  Optical transport network (OTN) refers to the transport of data, voice and video traffic over long distances using optical technologies. OTN solutions facilitate transmission bandwidth rates ranging from 10Gbit/s to over 100Gbit/s over existing fiber infrastructure. They deploy advanced multiplexing techniques such as dense wave division multiplexing (DWDM) and time-division multiplexing (TDM) that boost transmission and switching capabilities. OTN solutions deliver reduced latency and enhanced reliability for meeting rising bandwidth demands. The global Optical Transport Network Market is estimated to be valued at US$ 22.32 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The rising deployment of 400G networks across internet data centers and telecom backbones is estimated to present lucrative growth opportuniti...
Read more

Ostomy Care Accessories Market Is Estimated To Witness High Growth Owing To Opportunity In Improving Patient Lifestyles

Image
Ostomy Care Accessories Market Ostomy accessories are medical devices used along with an ostomy appliance or pouching system to help improve the quality of life of people who have had ostomy surgery. Some common ostomy accessories include belt or pants/undergarment clips, skin barriers, moisture-collecting bags, adhesive removers, and protecting sheets. The growing number of patients suffering from inflammatory bowel disease, colorectal cancer, and other gastrointestinal disorders have resulted in increasing demand for ostomy care accessories. These accessories play a crucial role in providing security, discretion, and comfort to ostomates while performing regular activities. The global Ostomy Care Accessories Market is estimated to be valued at US$ 3.69 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: Improving patient lifestyles is one of the major...
Read more

Schmallenberg Virus Treatment Is Estimated To Witness High Growth Owing To Opportunity Of Development Of New Drugs And Vaccines

Image
Schmallenberg Virus Treatment Market Schmallenberg virus (SBV) is an orthobunyavirus that affects domestic and wild ruminants such as cattle, sheep and goats. The virus causes fever, diarrhea and decreased milk production in adult animals. In newborn animals, the virus can lead to arthrogryposis-hydranencephaly syndrome, which causes malformations of the limbs and heads. While there is currently no treatment for SBV infection, supportive treatment measures such as nutritional supplements can help address symptoms such as diarrhea and reduced milk production. Researchers are developing preventive drugs and vaccines to control the spread of the virus. The global Schmallenberg Virus Treatment Market is estimated to be valued at US$ 110 Mn in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The key opportunity for growth in the Schmallenberg virus treatment marke...
Read more